Stockreport

Travere Therapeutics (TVTX): Valuation Check After FDA Tailwinds and FSGS Expansion Hopes for FILSPARI [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF See our latest analysis for Travere Therapeutics. Those regulatory tailwinds have lit a fire under Travere's share price, with a 1 day share price return of 13.91 per [Read more]